Patent · US Expired

Substituted pteridines for the treatment of inflammatory diseases

US7550472B2 · kind B2 · utility

4Cited by

3References

12Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Horst Dollinger · Schemmerhofen, DE
Juergen Mack · Biberach an der Riß, DE
Domnic Martyres · Biberach, DE
Birgit Jung · Laupheim, DE
Peter Nickolaus · Warthausen, DE

Key dates

Filing date	Nov 18, 2005
Grant date	Jun 23, 2009
Priority date	—
Expiry date	Nov 18, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new pteridines which are suitable for the treatment of

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.